In yesterday’s Wall Street session, Agilon Health Inc (NYSE:AGL) shares traded at $2.79, down -3.13% from the previous session.
AGL stock price is now -15.68% away from the 50-day moving average and -46.59% away from the 200-day moving average. The market capitalization of the company currently stands at $1.15B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $7 to $2.50, Citigroup Downgraded its rating from Neutral to Sell for Agilon Health Inc (NYSE: AGL). On October 02, 2024, BofA Securities Downgraded its previous ‘Buy’ rating to ‘Underperform’ on the stock keeping its target price maintained at $3, while ‘Robert W. Baird’ rates the stock as ‘Neutral’
In other news, Sell Steven, CEO & President bought 20,000 shares of the company’s stock on Sep 12 ’24. The stock was bought for $67,188 at an average price of $3.36. Upon completion of the transaction, the CEO & President now directly owns 67,590 shares in the company, valued at $0.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 29 ’23, Director Schwaneke Jeffrey A. bought 22,300 shares of the business’s stock. A total of $250,206 was incurred on buying the stock at an average price of $11.22. This leaves the insider owning 31,931 shares of the company worth $89087.49. A total of 26.41% of the company’s stock is owned by insiders.
During the past 12 months, Agilon Health Inc has had a low of $2.36 and a high of $13.98. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 1.36, and a quick ratio of 1.36. The fifty day moving average price for AGL is $3.3368 and a two-hundred day moving average price translates $5.24265 for the stock.
The latest earnings results from Agilon Health Inc (NYSE: AGL) was released for 2024-06-30. The net profit margin was -4.69% and return on equity was -29.03% for AGL. The company reported revenue of $1.48 billion for the quarter, compared to $1.07 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 38.69 percent.
